The shrinking U.S.-India interest rate differentials have sent the rupee/dollar forward premiums plunging. Last week, the 1-year forward implied yield dropped to 1.70%, not too far from the 1.61% in December 2022, the lowest in more than a decade.

Read More

​ The shrinking U.S.-India interest rate differentials have sent the rupee/dollar forward premiums plunging. Last week, the 1-year forward implied yield dropped to 1.70%, not too far from the 1.61% in December 2022, the lowest in more than a decade. The shrinking U.S.-India interest rate differentials have sent the rupee/dollar forward premiums plunging. Last week, the 1-year forward implied yield dropped to 1.70%, not too far from the 1.61% in December 2022, the lowest in more than a decade.  Moneycontrol Latest News Read More  

The shrinking U.S.-India interest rate differentials have sent the rupee/dollar forward premiums plunging. Last week, the 1-year forward implied yield dropped to 1.70%, not too far from the 1.61% in December 2022, the lowest in more than a decade.

MPC member Jayanth Varma says he disagrees strongly with the idea that the rate-setting panel should communicate mainly to an #39;inside#39; audience of regulated entities in a coded language

Read More

​ MPC member Jayanth Varma says he disagrees strongly with the idea that the rate-setting panel should communicate mainly to an #39;inside#39; audience of regulated entities in a coded language MPC member Jayanth Varma says he disagrees strongly with the idea that the rate-setting panel should communicate mainly to an #39;inside#39; audience of regulated entities in a coded language  Moneycontrol Latest News Read More  

MPC member Jayanth Varma says he disagrees strongly with the idea that the rate-setting panel should communicate mainly to an #39;inside#39; audience of regulated entities in a coded language

NULL

Read More

​ NULL NULL  Moneycontrol Latest News Read More  

NULL

IndusInd Bank stock price has experienced a recovery following a retest of the breakout level of horizontal trendline support. The stock recently broke out and climbed above its previous high, generating upward momentum

Read More

​ IndusInd Bank stock price has experienced a recovery following a retest of the breakout level of horizontal trendline support. The stock recently broke out and climbed above its previous high, generating upward momentum IndusInd Bank stock price has experienced a recovery following a retest of the breakout level of horizontal trendline support. The stock recently broke out and climbed above its previous high, generating upward momentum  Moneycontrol Latest News Read More  

IndusInd Bank stock price has experienced a recovery following a retest of the breakout level of horizontal trendline support. The stock recently broke out and climbed above its previous high, generating upward momentum

Sai Kabir’s #39;Tiku Weds Sheru#39; isn#39;t a #39;Tanu Weds Manu#39;. A cautionary tale about the City of Dreams masquerading as a cheeky rom-com, as punchlines and humour fizzle out, the film gets dark, preachy, boring, and problematic. Nawazuddin Siddique should stick to essaying cishet men and choose better writing.

Read More

​ Sai Kabir’s #39;Tiku Weds Sheru#39; isn#39;t a #39;Tanu Weds Manu#39;. A cautionary tale about the City of Dreams masquerading as a cheeky rom-com, as punchlines and humour fizzle out, the film gets dark, preachy, boring, and problematic. Nawazuddin Siddique should stick to essaying cishet men and choose better writing. Sai Kabir’s #39;Tiku Weds Sheru#39; isn#39;t a #39;Tanu Weds Manu#39;. A cautionary tale about the City of Dreams masquerading as a cheeky rom-com, as punchlines and humour fizzle out, the film gets dark, preachy, boring, and problematic. Nawazuddin Siddique should stick to essaying cishet men and choose better writing.  Moneycontrol Latest News Read More  

Sai Kabir’s #39;Tiku Weds Sheru#39; isn#39;t a #39;Tanu Weds Manu#39;. A cautionary tale about the City of Dreams masquerading as a cheeky rom-com, as punchlines and humour fizzle out, the film gets dark, preachy, boring, and problematic. Nawazuddin Siddique should stick to essaying cishet men and choose better writing.

The minister of road transport and highway said more attention needs to be given to the agricultural, rural and tribal sectors, and pointed out that the objective of each government policy must be to double the contribution to GDP of these segments to 25 per cent from the present 12 per cent.

Read More

​ The minister of road transport and highway said more attention needs to be given to the agricultural, rural and tribal sectors, and pointed out that the objective of each government policy must be to double the contribution to GDP of these segments to 25 per cent from the present 12 per cent. The minister of road transport and highway said more attention needs to be given to the agricultural, rural and tribal sectors, and pointed out that the objective of each government policy must be to double the contribution to GDP of these segments to 25 per cent from the present 12 per cent.  Moneycontrol Latest News Read More  

The minister of road transport and highway said more attention needs to be given to the agricultural, rural and tribal sectors, and pointed out that the objective of each government policy must be to double the contribution to GDP of these segments to 25 per cent from the present 12 per cent.

NULL

Read More

​ NULL NULL  Moneycontrol Latest News Read More  

NULL

The IPO consists of a fresh issue of upto 18.26 million shares and an offer for sale of upto 7.73 million shares by its promoter Pravin Kumar Agarwal.

Read More

​ The IPO consists of a fresh issue of upto 18.26 million shares and an offer for sale of upto 7.73 million shares by its promoter Pravin Kumar Agarwal. The IPO consists of a fresh issue of upto 18.26 million shares and an offer for sale of upto 7.73 million shares by its promoter Pravin Kumar Agarwal.  Moneycontrol Latest News Read More  

The IPO consists of a fresh issue of upto 18.26 million shares and an offer for sale of upto 7.73 million shares by its promoter Pravin Kumar Agarwal.

Acting, plot, direction — #39;The Idol#39; falters in every department. But what is the controversy surrounding the show about? Why is #39;The Idol#39; receiving backlash from viewers? And why is The Weeknd embarrassing himself?

Read More

​ Acting, plot, direction — #39;The Idol#39; falters in every department. But what is the controversy surrounding the show about? Why is #39;The Idol#39; receiving backlash from viewers? And why is The Weeknd embarrassing himself? Acting, plot, direction — #39;The Idol#39; falters in every department. But what is the controversy surrounding the show about? Why is #39;The Idol#39; receiving backlash from viewers? And why is The Weeknd embarrassing himself?  Moneycontrol Latest News Read More  

Acting, plot, direction — #39;The Idol#39; falters in every department. But what is the controversy surrounding the show about? Why is #39;The Idol#39; receiving backlash from viewers? And why is The Weeknd embarrassing himself?

The sub-licensing agreement for Nilotinib capsules, originally developed by Novartis, will be in 44 low and middle-income countries (LMIC), including the seven countries where patents on the product are pending or in force, Aurobindo Pharma said in a regulatory filing.

Read More

​ The sub-licensing agreement for Nilotinib capsules, originally developed by Novartis, will be in 44 low and middle-income countries (LMIC), including the seven countries where patents on the product are pending or in force, Aurobindo Pharma said in a regulatory filing. The sub-licensing agreement for Nilotinib capsules, originally developed by Novartis, will be in 44 low and middle-income countries (LMIC), including the seven countries where patents on the product are pending or in force, Aurobindo Pharma said in a regulatory filing.  Moneycontrol Latest News Read More  

The sub-licensing agreement for Nilotinib capsules, originally developed by Novartis, will be in 44 low and middle-income countries (LMIC), including the seven countries where patents on the product are pending or in force, Aurobindo Pharma said in a regulatory filing.